# Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time

> **NCT00809536** · PHASE1 · TERMINATED · sponsor: **Pfizer** · enrollment: 24 (actual)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DRUG:** Metformin
- **DRUG:** Metformin
- **DRUG:** PD 0332334
- **DRUG:** PD 0332334

## Key facts

- **NCT ID:** NCT00809536
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Please Detailed Description for termination reason.
- **Last updated:** 2010-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00809536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00809536, "Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00809536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*